Researchers at INRA have just uncovered one of the major genes responsible for female differentiation: FOXL2.
Studying sex reversals for answers
During normal development, the formation of testes or ovaries in a fetus depends on the presence or absence of the SRYgene, carried by the Y chromosome. However, instances of sex reversal have been observed, where fetuses carrying two X chromosomes, which are programed to develop an ovary, are actually born with all of the characteristics of a male. For more than a decade, researchers at INRA’s Developmental Biology and Reproduction unit in Jouy-en-Josas have been studying and characterizing the mutations responsible for XX males in domesticated animal species such as goats, exposing the importance of a gene (FOXL2) carried by an autosome (not a sex chromosome).
To demonstrate this gene’s role in determining gender, the researchers successfully silenced the FOXL2 gene in goat embryos using new genetic modification techniques. The XX fetuses that no longer had the FOXL2 gene developed testes instead of ovaries.
Ovaries: to exist, a double front to fight
The female development process was long considered the “default” differentiation process. The experiments carried out by the INRA team prove the opposite: that for ovaries to form, feminine genes must be activated and an active process of silencing must take place to override male development. The FOXL2 gene acts as a defender of the ovary; as the essential female gene, it silences male genes from the moment the ovary begins to form and a priori throughout development and until adulthood.
A model for studying for female fertility
The FOXL2 gene was already thought to play an important role in ovarian function in women. The inactivation of one of the two copies of this gene (heterozygous mutation) can in fact cause premature menopause in young women. Thanks to the techniques elaborated by the Developmental Biology and Reproduction unit, a goat model is currently being created to develop innovative therapies (gene or cell) to treat certain causes of female infertility.
The study done by INRA – Paris.
